Does OMEZOL Cause Osteoporosis? the Risks of Long-term Use - Gastroenterology and Hepatology

Share to:

Does OMEZOL cause osteoporosis?


Hello, doctor.
After undergoing an upper gastrointestinal endoscopy, I was diagnosed with gastroesophageal reflux disease (GERD) and took Dexilant (dexlansoprazole) for four months.
The doctor mentioned that long-term use of this medication could lead to osteoporosis.
However, since health insurance only covers it for four months, I have now switched to OMEZOL (omeprazole) 20 mg, which is also used to treat GERD.
Could you please let me know if this medication also has the potential side effect of causing osteoporosis? Thank you.

Niming, 30~39 year old female. Ask Date: 2022/09/22

Dr. Chen Shidian reply Gastroenterology and Hepatology


Long-term use over several years may also lead to osteoporosis.

Reply Date: 2022/09/22

More Info


OMEZOL, which contains the active ingredient omeprazole, is a proton pump inhibitor (PPI) commonly used to treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. While PPIs are effective in reducing gastric acid production, there has been growing concern regarding their long-term use and potential side effects, including the risk of osteoporosis.

Research has indicated that long-term use of PPIs, including omeprazole, may be associated with an increased risk of osteoporosis and fractures. The mechanism behind this potential risk is believed to be related to the way PPIs affect calcium absorption. Gastric acid plays a crucial role in the absorption of certain nutrients, including calcium. By significantly reducing stomach acid, PPIs can impair the body's ability to absorb calcium effectively, which is essential for maintaining bone density. Over time, this can lead to decreased bone mineral density and an increased risk of osteoporosis, particularly in individuals who are already at risk due to age or other factors.

In addition to osteoporosis, long-term PPI use has been linked to other potential side effects, such as kidney disease, gastrointestinal infections, and deficiencies in certain vitamins and minerals, including magnesium and vitamin B12. These risks underscore the importance of using PPIs judiciously and under the guidance of a healthcare provider.

If you have been prescribed OMEZOL for an extended period, it is essential to have regular follow-ups with your healthcare provider. They may recommend monitoring your bone health, especially if you have other risk factors for osteoporosis, such as a family history of the disease, a sedentary lifestyle, smoking, or a low-calcium diet. In some cases, your doctor may suggest lifestyle modifications, dietary changes, or even supplementation with calcium and vitamin D to help mitigate the risk of bone loss.

Furthermore, if you are concerned about the long-term use of OMEZOL or any other PPI, it is worth discussing alternative treatment options with your healthcare provider. There are other medications and lifestyle changes that can help manage GERD symptoms without the potential risks associated with long-term PPI use. These may include H2 receptor antagonists, lifestyle modifications (such as weight loss, dietary changes, and elevating the head of the bed), and antacids.

In conclusion, while OMEZOL is effective for treating GERD, long-term use may carry risks, including osteoporosis. It is crucial to have open discussions with your healthcare provider about the benefits and risks of continued PPI therapy, as well as potential alternatives and strategies to protect your bone health. Regular monitoring and proactive management can help ensure that you maintain both gastrointestinal health and overall well-being.

Similar Q&A

Understanding Osteoporosis Medications: Side Effects and Allergies Explained

Dear Pharmacist Lai, Thank you for answering my question. I would like to inquire about medication information regarding osteoporosis. My grandmother, who is 76 years old and lives in Canada, is using a medication called "Didrocal," which contains a total of 90 tablets...


Dr. Lai Shuyi reply Pharmacology
Hello: The side effects of this medication commonly include nausea and vomiting in the gastrointestinal tract; in the central nervous system, it may cause memory loss, depression, hallucinations, and abnormal skin sensations; in the musculoskeletal system, some studies indicate t...

[Read More] Understanding Osteoporosis Medications: Side Effects and Allergies Explained


Managing Osteoporosis in Seniors: Tips for Improving Bone Health and Sleep

Hello Doctor: My mother is 60 years old and recently had a bone density test with a result of -3.8. I would like to ask what should be done. My mother has Sjögren's syndrome and hepatitis C, and in recent years, she has been having trouble sleeping at night, relying on psych...


Dr. Chu Baijun reply Orthopedics
Hello Ms. Lin: Your mother's bone mineral density test result shows a T-score of -3.8, which meets the criteria for osteoporosis. Osteoporosis is a systemic condition characterized by a decrease in bone mass and deterioration of bone microarchitecture, leading to increased f...

[Read More] Managing Osteoporosis in Seniors: Tips for Improving Bone Health and Sleep


Understanding Osteoporosis Risks with Leuprolide Treatment in Women

Does receiving treatment with leuprolide (Lupron) cause osteoporosis? I received two doses of long-acting leuprolide six months ago and have been menopausal for six months. However, during these six months, I have only occasionally consumed milk, which may not be sufficient. Is i...


Dr. Cao Guotao reply Obstetrics and Gynecology
Hello, short-term use generally does not have an impact; a regular diet is sufficient. Of course, supplementation is also acceptable. Wishing you good health!

[Read More] Understanding Osteoporosis Risks with Leuprolide Treatment in Women


Alternatives to SSRIs: Managing Anxiety Without Bone Density Loss

Dear Doctor, I have been taking Clonazepam 12.5mg for about 10 years due to anxiety and panic issues. I also have osteoporosis that requires treatment. I found on Google that SSRIs can have side effects related to osteoporosis. I would like to ask if there are any other medicatio...


Dr. Wang Yaoting reply Psychiatry
Hello: Research from abroad indicates that SSRIs, a class of antidepressants that regulate serotonin, may reduce bone density in individuals aged 65 and older. In high-risk groups (those with osteoporosis or a history of fractures), caution is advised when using these medications...

[Read More] Alternatives to SSRIs: Managing Anxiety Without Bone Density Loss


Related FAQ

Osteoporosis

(Orthopedics)

Medication Side Effects

(Gastroenterology and Hepatology)

Liver Fibrosis

(Gastroenterology and Hepatology)

Health Check-Up Report

(Gastroenterology and Hepatology)

Cholecystitis

(Gastroenterology and Hepatology)

Medication And Diet

(Gastroenterology and Hepatology)

Probiotics

(Gastroenterology and Hepatology)

Gastric Ptosis

(Gastroenterology and Hepatology)

Halitosis

(Gastroenterology and Hepatology)

Accidental Ingestion

(Gastroenterology and Hepatology)